rdf:type |
|
lifeskim:mentions |
umls-concept:C0007102,
umls-concept:C0035020,
umls-concept:C0085862,
umls-concept:C0132299,
umls-concept:C0441767,
umls-concept:C0441914,
umls-concept:C0728940,
umls-concept:C1171362,
umls-concept:C1299583,
umls-concept:C1512896,
umls-concept:C1516213,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1880198,
umls-concept:C2698872
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-11
|
pubmed:abstractText |
S100 calcium-binding proteins such as S100B are elevated in primary malignant melanoma and are used as tumor markers for malignant melanoma and numerous other cancers. The purpose of this study was to identify the novel predictors of early relapse in UICC stages II and III colon cancer patients and thus to identify a subgroup of patients who are at high risk for postoperative early relapse.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1534-4681
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-45
|
pubmed:meshHeading |
pubmed-meshheading:20628824-Adult,
pubmed-meshheading:20628824-Aged,
pubmed-meshheading:20628824-Aged, 80 and over,
pubmed-meshheading:20628824-Colonic Neoplasms,
pubmed-meshheading:20628824-Female,
pubmed-meshheading:20628824-Follow-Up Studies,
pubmed-meshheading:20628824-Humans,
pubmed-meshheading:20628824-Immunoenzyme Techniques,
pubmed-meshheading:20628824-Male,
pubmed-meshheading:20628824-Middle Aged,
pubmed-meshheading:20628824-Neoplasm Recurrence, Local,
pubmed-meshheading:20628824-Neoplasm Staging,
pubmed-meshheading:20628824-Nerve Growth Factors,
pubmed-meshheading:20628824-Prognosis,
pubmed-meshheading:20628824-Retrospective Studies,
pubmed-meshheading:20628824-S100 Proteins,
pubmed-meshheading:20628824-Survival Rate,
pubmed-meshheading:20628824-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection.
|
pubmed:affiliation |
Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|